Skip to main content
logo
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
5.50
-0.26 (-4.51%)
At close: May 14, 2026, 4:00 PM EDT
5.51
+0.01 (0.18%)
After-hours: May 14, 2026, 6:35 PM EDT

Lexeo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
432725218358--
Market Cap Growth
231.85%233.12%-39.15%---
Enterprise Value
246.19548.35103.35245.1600
Last Close Price
5.509.936.5813.42--
PE Ratio
--5.34-2.13-1.08--
PB Ratio
1.762.941.863.15--
P/TBV Ratio
1.562.161.790.63--
P/FCF Ratio
--7.33-2.67-6.00--
P/OCF Ratio
--7.35-2.68-6.01--
EV/EBITDA Ratio
--5.03-0.98-3.59--
EV/EBIT Ratio
--5.02-0.98-3.58--
EV/FCF Ratio
--5.54-1.27-4.11--
Debt / Equity Ratio
0.020.020.060.080.150
Debt / EBITDA Ratio
-0.08-0.07-0.09-0.17-0.22-
Debt / FCF Ratio
-0.07-0.08-0.12-0.19-0.24-
Net Debt / Equity Ratio
-0.80-0.70-0.95-0.970.562.44
Net Debt / EBITDA Ratio
1.901.601.061.611.062.68
Net Debt / FCF Ratio
1.891.761.371.841.163.06
Asset Turnover
-0000.010.02
Quick Ratio
13.6110.815.327.055.3918.24
Current Ratio
14.1611.215.527.215.5818.35
Return on Equity (ROE)
-36.60%-55.00%-85.37%-71.54%-58.84%-65.27%
Return on Assets (ROA)
-37.68%-52.57%-73.77%-57.85%-51.73%-60.91%
Return on Invested Capital (ROIC)
-164.89%-280.02%-2362.17%-1101.58%-4235.84%1650.93%
Return on Capital Employed (ROCE)
-40.07%-58.12%-85.76%-66.75%-57.05%-64.05%
Earnings Yield
-20.26%-18.73%-46.96%-92.40%--
FCF Yield
-22.79%-13.65%-37.51%-16.67%--
Buyback Yield / Dilution
-98.55%-68.76%-493.67%-228.42%-5.00%-7.72%
Total Shareholder Return
-98.55%-68.76%-493.67%-228.42%-5.00%-7.72%
Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q